Global Drug Discovery Software Market

Drug Discovery Software Comprehensive Study by Type (Early Drug Discovery,, Pre-Clinical Phase,, Clinical Phases, and Regulatory Approval.), Application (Pharmaceutical Industry, Biotechnology Industry), Deployment Mode (Cloud Based, Web Based), Organization Size (Small & Medium Size Organizations, Large Organizations), End Users (R&D scientists, Clinical trial organizers, managers, analysts) Players and Region - Global Market Outlook to 2028

Drug Discovery Software Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Drug Discovery SoftwareMarket?
Drug discovery software is used to develop new pharmaceutical drugs and test whether a newly created drug will be effective in treating a particular disease. Drug discovery software automates and leverages innovative technology that significantly cuts down on the arduous process of drug development, testing, and going to market. Most drug discovery solutions offer screening, predictive analytics, modeling, simulation, and computational capabilities. Those functionalities help with tasks such as image analysis and clinical trial results submission, as well as ensuring accurate reproducibility. Researchers and scientists use drug discovery software to gain market intelligence, take advantage of advancements in drug design and synthesis, tackle evolving and adapting diseases, and maintain and manage the integrity of data as drugs transition from the discovery phase to the clinical trial phase.

Drug Discovery Software Market Report Coverage
Report CoverageDetails
Study Timeframe2018 to 2028
Base Year2022
Growth Drivers
  • The Growing Pharmaceutical Industry Worldwide
  • Surged R&D Activities in the Pharmaceutical Industry
  • Growing Automation in the Drug Discovery Processes
  • The Increasing Demand for the COVID-19 Drug Discovery
  • The Upsurging Demand for the Drug Discovery Owing to the Expiration of Patents
  • The Software Helps Pharmaceutical Companies to Remain Competitive In the Drug Market
Challenges & Pitfalls
  • Unknown Regulation Complications and Duplication Problems


Opportunities
The Growing Demand for the Drug Discovery Software from the Asia Pacific Region

Restraints
  • Nanoparticles and nanoformulations allow for better drug penetration through the skin, improving the efficacy of transdermal delivery.


The Players Covered in the Study are:
Epocrates (United States), Thermo Scientific Nautilus LIMS (United States), ChemDraw (PerkinElmer) (United States), MicroTracker (Norway), DrugPatentWatch (United States), AutoDock (Scripps Research) (United States), Collaborative Drug Discovery Inc. (United States), DrugDev Spark (United States), DSG Drug Safety (United States) and PEPID PDC (United States)

Available Customization:
A list of players that can be included in the study on an immediate basis are Schrodinger Discovery Informatics Suite (United States), Advera Health (United States), American Gene Technologies (United States), Aurora Drug Discovery Software (United States) and BIOVIA Discovery Studio (United States).


Market Development Activities
In June , 2018 Therapeutic Research Center (TRC Healthcare, or TRC), a leading provider of medication advisory and learning solutions, in partnership with athenahealth, will deliver select medication therapy clinical resources and advisory articles each month, from the most recently published issue of Prescriber's Letter.

In Dec. , 2023 Merck, a leading science and technology company, today launched its AIDDISON™ drug discovery software, the first software-as-a-service platform that bridges the gap between virtual molecule design and real-world manufacturability through SynthiaTM retrosynthesis software application programing interface (API) integration.

Report Objectives / Segmentation Covered

By Type
  • Early Drug Discovery,
  • Pre-Clinical Phase,
  • Clinical Phases, and Regulatory Approval.
By Application
  • Pharmaceutical Industry
  • Biotechnology Industry
By Deployment Mode
  • Cloud Based
  • Web Based

By Organization Size
  • Small & Medium Size Organizations
  • Large Organizations

By End Users
  • R&D scientists
  • Clinical trial organizers, managers, analysts

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The Growing Pharmaceutical Industry Worldwide
      • 3.2.2. Surged R&D Activities in the Pharmaceutical Industry
      • 3.2.3. Growing Automation in the Drug Discovery Processes
      • 3.2.4. The Increasing Demand for the COVID-19 Drug Discovery
      • 3.2.5. The Upsurging Demand for the Drug Discovery Owing to the Expiration of Patents
      • 3.2.6. The Software Helps Pharmaceutical Companies to Remain Competitive In the Drug Market
    • 3.3. Market Challenges
      • 3.3.1. Unknown Regulation Complications and Duplication Problems
    • 3.4. Market Trends
      • 3.4.1. Rapidly Adoption of the Artificial Intelligence and Deep Learning Technology
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Drug Discovery Software, by Type, Application, Deployment Mode, Organization Size, End Users and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Drug Discovery Software (Value)
      • 5.2.1. Global Drug Discovery Software by: Type (Value)
        • 5.2.1.1. Early Drug Discovery,
        • 5.2.1.2. Pre-Clinical Phase,
        • 5.2.1.3. Clinical Phases, and Regulatory Approval.
      • 5.2.2. Global Drug Discovery Software by: Application (Value)
        • 5.2.2.1. Pharmaceutical Industry
        • 5.2.2.2. Biotechnology Industry
      • 5.2.3. Global Drug Discovery Software by: Deployment Mode (Value)
        • 5.2.3.1. Cloud Based
        • 5.2.3.2. Web Based
      • 5.2.4. Global Drug Discovery Software by: Organization Size (Value)
        • 5.2.4.1. Small & Medium Size Organizations
        • 5.2.4.2. Large Organizations
      • 5.2.5. Global Drug Discovery Software by: End Users (Value)
        • 5.2.5.1. R&D scientists
        • 5.2.5.2. Clinical trial organizers, managers, analysts
      • 5.2.6. Global Drug Discovery Software Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Drug Discovery Software (Price)
      • 5.3.1. Global Drug Discovery Software by: Type (Price)
  • 6. Drug Discovery Software: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Epocrates (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Thermo Scientific Nautilus LIMS (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. ChemDraw (PerkinElmer) (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. MicroTracker (Norway)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. DrugPatentWatch (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. AutoDock (Scripps Research) (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Collaborative Drug Discovery Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. DrugDev Spark (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. DSG Drug Safety (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. PEPID PDC (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Drug Discovery Software Sale, by Type, Application, Deployment Mode, Organization Size, End Users and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Drug Discovery Software (Value)
      • 7.2.1. Global Drug Discovery Software by: Type (Value)
        • 7.2.1.1. Early Drug Discovery,
        • 7.2.1.2. Pre-Clinical Phase,
        • 7.2.1.3. Clinical Phases, and Regulatory Approval.
      • 7.2.2. Global Drug Discovery Software by: Application (Value)
        • 7.2.2.1. Pharmaceutical Industry
        • 7.2.2.2. Biotechnology Industry
      • 7.2.3. Global Drug Discovery Software by: Deployment Mode (Value)
        • 7.2.3.1. Cloud Based
        • 7.2.3.2. Web Based
      • 7.2.4. Global Drug Discovery Software by: Organization Size (Value)
        • 7.2.4.1. Small & Medium Size Organizations
        • 7.2.4.2. Large Organizations
      • 7.2.5. Global Drug Discovery Software by: End Users (Value)
        • 7.2.5.1. R&D scientists
        • 7.2.5.2. Clinical trial organizers, managers, analysts
      • 7.2.6. Global Drug Discovery Software Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Drug Discovery Software (Price)
      • 7.3.1. Global Drug Discovery Software by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Drug Discovery Software: by Type(USD Million)
  • Table 2. Drug Discovery Software Early Drug Discovery, , by Region USD Million (2017-2022)
  • Table 3. Drug Discovery Software Pre-Clinical Phase, , by Region USD Million (2017-2022)
  • Table 4. Drug Discovery Software Clinical Phases, and Regulatory Approval. , by Region USD Million (2017-2022)
  • Table 5. Drug Discovery Software: by Application(USD Million)
  • Table 6. Drug Discovery Software Pharmaceutical Industry , by Region USD Million (2017-2022)
  • Table 7. Drug Discovery Software Biotechnology Industry , by Region USD Million (2017-2022)
  • Table 8. Drug Discovery Software: by Deployment Mode(USD Million)
  • Table 9. Drug Discovery Software Cloud Based , by Region USD Million (2017-2022)
  • Table 10. Drug Discovery Software Web Based , by Region USD Million (2017-2022)
  • Table 11. Drug Discovery Software: by Organization Size(USD Million)
  • Table 12. Drug Discovery Software Small & Medium Size Organizations , by Region USD Million (2017-2022)
  • Table 13. Drug Discovery Software Large Organizations , by Region USD Million (2017-2022)
  • Table 14. Drug Discovery Software: by End Users(USD Million)
  • Table 15. Drug Discovery Software R&D scientists , by Region USD Million (2017-2022)
  • Table 16. Drug Discovery Software Clinical trial organizers, managers, analysts , by Region USD Million (2017-2022)
  • Table 17. South America Drug Discovery Software, by Country USD Million (2017-2022)
  • Table 18. South America Drug Discovery Software, by Type USD Million (2017-2022)
  • Table 19. South America Drug Discovery Software, by Application USD Million (2017-2022)
  • Table 20. South America Drug Discovery Software, by Deployment Mode USD Million (2017-2022)
  • Table 21. South America Drug Discovery Software, by Organization Size USD Million (2017-2022)
  • Table 22. South America Drug Discovery Software, by End Users USD Million (2017-2022)
  • Table 23. Brazil Drug Discovery Software, by Type USD Million (2017-2022)
  • Table 24. Brazil Drug Discovery Software, by Application USD Million (2017-2022)
  • Table 25. Brazil Drug Discovery Software, by Deployment Mode USD Million (2017-2022)
  • Table 26. Brazil Drug Discovery Software, by Organization Size USD Million (2017-2022)
  • Table 27. Brazil Drug Discovery Software, by End Users USD Million (2017-2022)
  • Table 28. Argentina Drug Discovery Software, by Type USD Million (2017-2022)
  • Table 29. Argentina Drug Discovery Software, by Application USD Million (2017-2022)
  • Table 30. Argentina Drug Discovery Software, by Deployment Mode USD Million (2017-2022)
  • Table 31. Argentina Drug Discovery Software, by Organization Size USD Million (2017-2022)
  • Table 32. Argentina Drug Discovery Software, by End Users USD Million (2017-2022)
  • Table 33. Rest of South America Drug Discovery Software, by Type USD Million (2017-2022)
  • Table 34. Rest of South America Drug Discovery Software, by Application USD Million (2017-2022)
  • Table 35. Rest of South America Drug Discovery Software, by Deployment Mode USD Million (2017-2022)
  • Table 36. Rest of South America Drug Discovery Software, by Organization Size USD Million (2017-2022)
  • Table 37. Rest of South America Drug Discovery Software, by End Users USD Million (2017-2022)
  • Table 38. Asia Pacific Drug Discovery Software, by Country USD Million (2017-2022)
  • Table 39. Asia Pacific Drug Discovery Software, by Type USD Million (2017-2022)
  • Table 40. Asia Pacific Drug Discovery Software, by Application USD Million (2017-2022)
  • Table 41. Asia Pacific Drug Discovery Software, by Deployment Mode USD Million (2017-2022)
  • Table 42. Asia Pacific Drug Discovery Software, by Organization Size USD Million (2017-2022)
  • Table 43. Asia Pacific Drug Discovery Software, by End Users USD Million (2017-2022)
  • Table 44. China Drug Discovery Software, by Type USD Million (2017-2022)
  • Table 45. China Drug Discovery Software, by Application USD Million (2017-2022)
  • Table 46. China Drug Discovery Software, by Deployment Mode USD Million (2017-2022)
  • Table 47. China Drug Discovery Software, by Organization Size USD Million (2017-2022)
  • Table 48. China Drug Discovery Software, by End Users USD Million (2017-2022)
  • Table 49. Japan Drug Discovery Software, by Type USD Million (2017-2022)
  • Table 50. Japan Drug Discovery Software, by Application USD Million (2017-2022)
  • Table 51. Japan Drug Discovery Software, by Deployment Mode USD Million (2017-2022)
  • Table 52. Japan Drug Discovery Software, by Organization Size USD Million (2017-2022)
  • Table 53. Japan Drug Discovery Software, by End Users USD Million (2017-2022)
  • Table 54. India Drug Discovery Software, by Type USD Million (2017-2022)
  • Table 55. India Drug Discovery Software, by Application USD Million (2017-2022)
  • Table 56. India Drug Discovery Software, by Deployment Mode USD Million (2017-2022)
  • Table 57. India Drug Discovery Software, by Organization Size USD Million (2017-2022)
  • Table 58. India Drug Discovery Software, by End Users USD Million (2017-2022)
  • Table 59. South Korea Drug Discovery Software, by Type USD Million (2017-2022)
  • Table 60. South Korea Drug Discovery Software, by Application USD Million (2017-2022)
  • Table 61. South Korea Drug Discovery Software, by Deployment Mode USD Million (2017-2022)
  • Table 62. South Korea Drug Discovery Software, by Organization Size USD Million (2017-2022)
  • Table 63. South Korea Drug Discovery Software, by End Users USD Million (2017-2022)
  • Table 64. Taiwan Drug Discovery Software, by Type USD Million (2017-2022)
  • Table 65. Taiwan Drug Discovery Software, by Application USD Million (2017-2022)
  • Table 66. Taiwan Drug Discovery Software, by Deployment Mode USD Million (2017-2022)
  • Table 67. Taiwan Drug Discovery Software, by Organization Size USD Million (2017-2022)
  • Table 68. Taiwan Drug Discovery Software, by End Users USD Million (2017-2022)
  • Table 69. Australia Drug Discovery Software, by Type USD Million (2017-2022)
  • Table 70. Australia Drug Discovery Software, by Application USD Million (2017-2022)
  • Table 71. Australia Drug Discovery Software, by Deployment Mode USD Million (2017-2022)
  • Table 72. Australia Drug Discovery Software, by Organization Size USD Million (2017-2022)
  • Table 73. Australia Drug Discovery Software, by End Users USD Million (2017-2022)
  • Table 74. Rest of Asia-Pacific Drug Discovery Software, by Type USD Million (2017-2022)
  • Table 75. Rest of Asia-Pacific Drug Discovery Software, by Application USD Million (2017-2022)
  • Table 76. Rest of Asia-Pacific Drug Discovery Software, by Deployment Mode USD Million (2017-2022)
  • Table 77. Rest of Asia-Pacific Drug Discovery Software, by Organization Size USD Million (2017-2022)
  • Table 78. Rest of Asia-Pacific Drug Discovery Software, by End Users USD Million (2017-2022)
  • Table 79. Europe Drug Discovery Software, by Country USD Million (2017-2022)
  • Table 80. Europe Drug Discovery Software, by Type USD Million (2017-2022)
  • Table 81. Europe Drug Discovery Software, by Application USD Million (2017-2022)
  • Table 82. Europe Drug Discovery Software, by Deployment Mode USD Million (2017-2022)
  • Table 83. Europe Drug Discovery Software, by Organization Size USD Million (2017-2022)
  • Table 84. Europe Drug Discovery Software, by End Users USD Million (2017-2022)
  • Table 85. Germany Drug Discovery Software, by Type USD Million (2017-2022)
  • Table 86. Germany Drug Discovery Software, by Application USD Million (2017-2022)
  • Table 87. Germany Drug Discovery Software, by Deployment Mode USD Million (2017-2022)
  • Table 88. Germany Drug Discovery Software, by Organization Size USD Million (2017-2022)
  • Table 89. Germany Drug Discovery Software, by End Users USD Million (2017-2022)
  • Table 90. France Drug Discovery Software, by Type USD Million (2017-2022)
  • Table 91. France Drug Discovery Software, by Application USD Million (2017-2022)
  • Table 92. France Drug Discovery Software, by Deployment Mode USD Million (2017-2022)
  • Table 93. France Drug Discovery Software, by Organization Size USD Million (2017-2022)
  • Table 94. France Drug Discovery Software, by End Users USD Million (2017-2022)
  • Table 95. Italy Drug Discovery Software, by Type USD Million (2017-2022)
  • Table 96. Italy Drug Discovery Software, by Application USD Million (2017-2022)
  • Table 97. Italy Drug Discovery Software, by Deployment Mode USD Million (2017-2022)
  • Table 98. Italy Drug Discovery Software, by Organization Size USD Million (2017-2022)
  • Table 99. Italy Drug Discovery Software, by End Users USD Million (2017-2022)
  • Table 100. United Kingdom Drug Discovery Software, by Type USD Million (2017-2022)
  • Table 101. United Kingdom Drug Discovery Software, by Application USD Million (2017-2022)
  • Table 102. United Kingdom Drug Discovery Software, by Deployment Mode USD Million (2017-2022)
  • Table 103. United Kingdom Drug Discovery Software, by Organization Size USD Million (2017-2022)
  • Table 104. United Kingdom Drug Discovery Software, by End Users USD Million (2017-2022)
  • Table 105. Netherlands Drug Discovery Software, by Type USD Million (2017-2022)
  • Table 106. Netherlands Drug Discovery Software, by Application USD Million (2017-2022)
  • Table 107. Netherlands Drug Discovery Software, by Deployment Mode USD Million (2017-2022)
  • Table 108. Netherlands Drug Discovery Software, by Organization Size USD Million (2017-2022)
  • Table 109. Netherlands Drug Discovery Software, by End Users USD Million (2017-2022)
  • Table 110. Rest of Europe Drug Discovery Software, by Type USD Million (2017-2022)
  • Table 111. Rest of Europe Drug Discovery Software, by Application USD Million (2017-2022)
  • Table 112. Rest of Europe Drug Discovery Software, by Deployment Mode USD Million (2017-2022)
  • Table 113. Rest of Europe Drug Discovery Software, by Organization Size USD Million (2017-2022)
  • Table 114. Rest of Europe Drug Discovery Software, by End Users USD Million (2017-2022)
  • Table 115. MEA Drug Discovery Software, by Country USD Million (2017-2022)
  • Table 116. MEA Drug Discovery Software, by Type USD Million (2017-2022)
  • Table 117. MEA Drug Discovery Software, by Application USD Million (2017-2022)
  • Table 118. MEA Drug Discovery Software, by Deployment Mode USD Million (2017-2022)
  • Table 119. MEA Drug Discovery Software, by Organization Size USD Million (2017-2022)
  • Table 120. MEA Drug Discovery Software, by End Users USD Million (2017-2022)
  • Table 121. Middle East Drug Discovery Software, by Type USD Million (2017-2022)
  • Table 122. Middle East Drug Discovery Software, by Application USD Million (2017-2022)
  • Table 123. Middle East Drug Discovery Software, by Deployment Mode USD Million (2017-2022)
  • Table 124. Middle East Drug Discovery Software, by Organization Size USD Million (2017-2022)
  • Table 125. Middle East Drug Discovery Software, by End Users USD Million (2017-2022)
  • Table 126. Africa Drug Discovery Software, by Type USD Million (2017-2022)
  • Table 127. Africa Drug Discovery Software, by Application USD Million (2017-2022)
  • Table 128. Africa Drug Discovery Software, by Deployment Mode USD Million (2017-2022)
  • Table 129. Africa Drug Discovery Software, by Organization Size USD Million (2017-2022)
  • Table 130. Africa Drug Discovery Software, by End Users USD Million (2017-2022)
  • Table 131. North America Drug Discovery Software, by Country USD Million (2017-2022)
  • Table 132. North America Drug Discovery Software, by Type USD Million (2017-2022)
  • Table 133. North America Drug Discovery Software, by Application USD Million (2017-2022)
  • Table 134. North America Drug Discovery Software, by Deployment Mode USD Million (2017-2022)
  • Table 135. North America Drug Discovery Software, by Organization Size USD Million (2017-2022)
  • Table 136. North America Drug Discovery Software, by End Users USD Million (2017-2022)
  • Table 137. United States Drug Discovery Software, by Type USD Million (2017-2022)
  • Table 138. United States Drug Discovery Software, by Application USD Million (2017-2022)
  • Table 139. United States Drug Discovery Software, by Deployment Mode USD Million (2017-2022)
  • Table 140. United States Drug Discovery Software, by Organization Size USD Million (2017-2022)
  • Table 141. United States Drug Discovery Software, by End Users USD Million (2017-2022)
  • Table 142. Canada Drug Discovery Software, by Type USD Million (2017-2022)
  • Table 143. Canada Drug Discovery Software, by Application USD Million (2017-2022)
  • Table 144. Canada Drug Discovery Software, by Deployment Mode USD Million (2017-2022)
  • Table 145. Canada Drug Discovery Software, by Organization Size USD Million (2017-2022)
  • Table 146. Canada Drug Discovery Software, by End Users USD Million (2017-2022)
  • Table 147. Mexico Drug Discovery Software, by Type USD Million (2017-2022)
  • Table 148. Mexico Drug Discovery Software, by Application USD Million (2017-2022)
  • Table 149. Mexico Drug Discovery Software, by Deployment Mode USD Million (2017-2022)
  • Table 150. Mexico Drug Discovery Software, by Organization Size USD Million (2017-2022)
  • Table 151. Mexico Drug Discovery Software, by End Users USD Million (2017-2022)
  • Table 152. Drug Discovery Software: by Type(USD/Units)
  • Table 153. Company Basic Information, Sales Area and Its Competitors
  • Table 154. Company Basic Information, Sales Area and Its Competitors
  • Table 155. Company Basic Information, Sales Area and Its Competitors
  • Table 156. Company Basic Information, Sales Area and Its Competitors
  • Table 157. Company Basic Information, Sales Area and Its Competitors
  • Table 158. Company Basic Information, Sales Area and Its Competitors
  • Table 159. Company Basic Information, Sales Area and Its Competitors
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Drug Discovery Software: by Type(USD Million)
  • Table 164. Drug Discovery Software Early Drug Discovery, , by Region USD Million (2023-2028)
  • Table 165. Drug Discovery Software Pre-Clinical Phase, , by Region USD Million (2023-2028)
  • Table 166. Drug Discovery Software Clinical Phases, and Regulatory Approval. , by Region USD Million (2023-2028)
  • Table 167. Drug Discovery Software: by Application(USD Million)
  • Table 168. Drug Discovery Software Pharmaceutical Industry , by Region USD Million (2023-2028)
  • Table 169. Drug Discovery Software Biotechnology Industry , by Region USD Million (2023-2028)
  • Table 170. Drug Discovery Software: by Deployment Mode(USD Million)
  • Table 171. Drug Discovery Software Cloud Based , by Region USD Million (2023-2028)
  • Table 172. Drug Discovery Software Web Based , by Region USD Million (2023-2028)
  • Table 173. Drug Discovery Software: by Organization Size(USD Million)
  • Table 174. Drug Discovery Software Small & Medium Size Organizations , by Region USD Million (2023-2028)
  • Table 175. Drug Discovery Software Large Organizations , by Region USD Million (2023-2028)
  • Table 176. Drug Discovery Software: by End Users(USD Million)
  • Table 177. Drug Discovery Software R&D scientists , by Region USD Million (2023-2028)
  • Table 178. Drug Discovery Software Clinical trial organizers, managers, analysts , by Region USD Million (2023-2028)
  • Table 179. South America Drug Discovery Software, by Country USD Million (2023-2028)
  • Table 180. South America Drug Discovery Software, by Type USD Million (2023-2028)
  • Table 181. South America Drug Discovery Software, by Application USD Million (2023-2028)
  • Table 182. South America Drug Discovery Software, by Deployment Mode USD Million (2023-2028)
  • Table 183. South America Drug Discovery Software, by Organization Size USD Million (2023-2028)
  • Table 184. South America Drug Discovery Software, by End Users USD Million (2023-2028)
  • Table 185. Brazil Drug Discovery Software, by Type USD Million (2023-2028)
  • Table 186. Brazil Drug Discovery Software, by Application USD Million (2023-2028)
  • Table 187. Brazil Drug Discovery Software, by Deployment Mode USD Million (2023-2028)
  • Table 188. Brazil Drug Discovery Software, by Organization Size USD Million (2023-2028)
  • Table 189. Brazil Drug Discovery Software, by End Users USD Million (2023-2028)
  • Table 190. Argentina Drug Discovery Software, by Type USD Million (2023-2028)
  • Table 191. Argentina Drug Discovery Software, by Application USD Million (2023-2028)
  • Table 192. Argentina Drug Discovery Software, by Deployment Mode USD Million (2023-2028)
  • Table 193. Argentina Drug Discovery Software, by Organization Size USD Million (2023-2028)
  • Table 194. Argentina Drug Discovery Software, by End Users USD Million (2023-2028)
  • Table 195. Rest of South America Drug Discovery Software, by Type USD Million (2023-2028)
  • Table 196. Rest of South America Drug Discovery Software, by Application USD Million (2023-2028)
  • Table 197. Rest of South America Drug Discovery Software, by Deployment Mode USD Million (2023-2028)
  • Table 198. Rest of South America Drug Discovery Software, by Organization Size USD Million (2023-2028)
  • Table 199. Rest of South America Drug Discovery Software, by End Users USD Million (2023-2028)
  • Table 200. Asia Pacific Drug Discovery Software, by Country USD Million (2023-2028)
  • Table 201. Asia Pacific Drug Discovery Software, by Type USD Million (2023-2028)
  • Table 202. Asia Pacific Drug Discovery Software, by Application USD Million (2023-2028)
  • Table 203. Asia Pacific Drug Discovery Software, by Deployment Mode USD Million (2023-2028)
  • Table 204. Asia Pacific Drug Discovery Software, by Organization Size USD Million (2023-2028)
  • Table 205. Asia Pacific Drug Discovery Software, by End Users USD Million (2023-2028)
  • Table 206. China Drug Discovery Software, by Type USD Million (2023-2028)
  • Table 207. China Drug Discovery Software, by Application USD Million (2023-2028)
  • Table 208. China Drug Discovery Software, by Deployment Mode USD Million (2023-2028)
  • Table 209. China Drug Discovery Software, by Organization Size USD Million (2023-2028)
  • Table 210. China Drug Discovery Software, by End Users USD Million (2023-2028)
  • Table 211. Japan Drug Discovery Software, by Type USD Million (2023-2028)
  • Table 212. Japan Drug Discovery Software, by Application USD Million (2023-2028)
  • Table 213. Japan Drug Discovery Software, by Deployment Mode USD Million (2023-2028)
  • Table 214. Japan Drug Discovery Software, by Organization Size USD Million (2023-2028)
  • Table 215. Japan Drug Discovery Software, by End Users USD Million (2023-2028)
  • Table 216. India Drug Discovery Software, by Type USD Million (2023-2028)
  • Table 217. India Drug Discovery Software, by Application USD Million (2023-2028)
  • Table 218. India Drug Discovery Software, by Deployment Mode USD Million (2023-2028)
  • Table 219. India Drug Discovery Software, by Organization Size USD Million (2023-2028)
  • Table 220. India Drug Discovery Software, by End Users USD Million (2023-2028)
  • Table 221. South Korea Drug Discovery Software, by Type USD Million (2023-2028)
  • Table 222. South Korea Drug Discovery Software, by Application USD Million (2023-2028)
  • Table 223. South Korea Drug Discovery Software, by Deployment Mode USD Million (2023-2028)
  • Table 224. South Korea Drug Discovery Software, by Organization Size USD Million (2023-2028)
  • Table 225. South Korea Drug Discovery Software, by End Users USD Million (2023-2028)
  • Table 226. Taiwan Drug Discovery Software, by Type USD Million (2023-2028)
  • Table 227. Taiwan Drug Discovery Software, by Application USD Million (2023-2028)
  • Table 228. Taiwan Drug Discovery Software, by Deployment Mode USD Million (2023-2028)
  • Table 229. Taiwan Drug Discovery Software, by Organization Size USD Million (2023-2028)
  • Table 230. Taiwan Drug Discovery Software, by End Users USD Million (2023-2028)
  • Table 231. Australia Drug Discovery Software, by Type USD Million (2023-2028)
  • Table 232. Australia Drug Discovery Software, by Application USD Million (2023-2028)
  • Table 233. Australia Drug Discovery Software, by Deployment Mode USD Million (2023-2028)
  • Table 234. Australia Drug Discovery Software, by Organization Size USD Million (2023-2028)
  • Table 235. Australia Drug Discovery Software, by End Users USD Million (2023-2028)
  • Table 236. Rest of Asia-Pacific Drug Discovery Software, by Type USD Million (2023-2028)
  • Table 237. Rest of Asia-Pacific Drug Discovery Software, by Application USD Million (2023-2028)
  • Table 238. Rest of Asia-Pacific Drug Discovery Software, by Deployment Mode USD Million (2023-2028)
  • Table 239. Rest of Asia-Pacific Drug Discovery Software, by Organization Size USD Million (2023-2028)
  • Table 240. Rest of Asia-Pacific Drug Discovery Software, by End Users USD Million (2023-2028)
  • Table 241. Europe Drug Discovery Software, by Country USD Million (2023-2028)
  • Table 242. Europe Drug Discovery Software, by Type USD Million (2023-2028)
  • Table 243. Europe Drug Discovery Software, by Application USD Million (2023-2028)
  • Table 244. Europe Drug Discovery Software, by Deployment Mode USD Million (2023-2028)
  • Table 245. Europe Drug Discovery Software, by Organization Size USD Million (2023-2028)
  • Table 246. Europe Drug Discovery Software, by End Users USD Million (2023-2028)
  • Table 247. Germany Drug Discovery Software, by Type USD Million (2023-2028)
  • Table 248. Germany Drug Discovery Software, by Application USD Million (2023-2028)
  • Table 249. Germany Drug Discovery Software, by Deployment Mode USD Million (2023-2028)
  • Table 250. Germany Drug Discovery Software, by Organization Size USD Million (2023-2028)
  • Table 251. Germany Drug Discovery Software, by End Users USD Million (2023-2028)
  • Table 252. France Drug Discovery Software, by Type USD Million (2023-2028)
  • Table 253. France Drug Discovery Software, by Application USD Million (2023-2028)
  • Table 254. France Drug Discovery Software, by Deployment Mode USD Million (2023-2028)
  • Table 255. France Drug Discovery Software, by Organization Size USD Million (2023-2028)
  • Table 256. France Drug Discovery Software, by End Users USD Million (2023-2028)
  • Table 257. Italy Drug Discovery Software, by Type USD Million (2023-2028)
  • Table 258. Italy Drug Discovery Software, by Application USD Million (2023-2028)
  • Table 259. Italy Drug Discovery Software, by Deployment Mode USD Million (2023-2028)
  • Table 260. Italy Drug Discovery Software, by Organization Size USD Million (2023-2028)
  • Table 261. Italy Drug Discovery Software, by End Users USD Million (2023-2028)
  • Table 262. United Kingdom Drug Discovery Software, by Type USD Million (2023-2028)
  • Table 263. United Kingdom Drug Discovery Software, by Application USD Million (2023-2028)
  • Table 264. United Kingdom Drug Discovery Software, by Deployment Mode USD Million (2023-2028)
  • Table 265. United Kingdom Drug Discovery Software, by Organization Size USD Million (2023-2028)
  • Table 266. United Kingdom Drug Discovery Software, by End Users USD Million (2023-2028)
  • Table 267. Netherlands Drug Discovery Software, by Type USD Million (2023-2028)
  • Table 268. Netherlands Drug Discovery Software, by Application USD Million (2023-2028)
  • Table 269. Netherlands Drug Discovery Software, by Deployment Mode USD Million (2023-2028)
  • Table 270. Netherlands Drug Discovery Software, by Organization Size USD Million (2023-2028)
  • Table 271. Netherlands Drug Discovery Software, by End Users USD Million (2023-2028)
  • Table 272. Rest of Europe Drug Discovery Software, by Type USD Million (2023-2028)
  • Table 273. Rest of Europe Drug Discovery Software, by Application USD Million (2023-2028)
  • Table 274. Rest of Europe Drug Discovery Software, by Deployment Mode USD Million (2023-2028)
  • Table 275. Rest of Europe Drug Discovery Software, by Organization Size USD Million (2023-2028)
  • Table 276. Rest of Europe Drug Discovery Software, by End Users USD Million (2023-2028)
  • Table 277. MEA Drug Discovery Software, by Country USD Million (2023-2028)
  • Table 278. MEA Drug Discovery Software, by Type USD Million (2023-2028)
  • Table 279. MEA Drug Discovery Software, by Application USD Million (2023-2028)
  • Table 280. MEA Drug Discovery Software, by Deployment Mode USD Million (2023-2028)
  • Table 281. MEA Drug Discovery Software, by Organization Size USD Million (2023-2028)
  • Table 282. MEA Drug Discovery Software, by End Users USD Million (2023-2028)
  • Table 283. Middle East Drug Discovery Software, by Type USD Million (2023-2028)
  • Table 284. Middle East Drug Discovery Software, by Application USD Million (2023-2028)
  • Table 285. Middle East Drug Discovery Software, by Deployment Mode USD Million (2023-2028)
  • Table 286. Middle East Drug Discovery Software, by Organization Size USD Million (2023-2028)
  • Table 287. Middle East Drug Discovery Software, by End Users USD Million (2023-2028)
  • Table 288. Africa Drug Discovery Software, by Type USD Million (2023-2028)
  • Table 289. Africa Drug Discovery Software, by Application USD Million (2023-2028)
  • Table 290. Africa Drug Discovery Software, by Deployment Mode USD Million (2023-2028)
  • Table 291. Africa Drug Discovery Software, by Organization Size USD Million (2023-2028)
  • Table 292. Africa Drug Discovery Software, by End Users USD Million (2023-2028)
  • Table 293. North America Drug Discovery Software, by Country USD Million (2023-2028)
  • Table 294. North America Drug Discovery Software, by Type USD Million (2023-2028)
  • Table 295. North America Drug Discovery Software, by Application USD Million (2023-2028)
  • Table 296. North America Drug Discovery Software, by Deployment Mode USD Million (2023-2028)
  • Table 297. North America Drug Discovery Software, by Organization Size USD Million (2023-2028)
  • Table 298. North America Drug Discovery Software, by End Users USD Million (2023-2028)
  • Table 299. United States Drug Discovery Software, by Type USD Million (2023-2028)
  • Table 300. United States Drug Discovery Software, by Application USD Million (2023-2028)
  • Table 301. United States Drug Discovery Software, by Deployment Mode USD Million (2023-2028)
  • Table 302. United States Drug Discovery Software, by Organization Size USD Million (2023-2028)
  • Table 303. United States Drug Discovery Software, by End Users USD Million (2023-2028)
  • Table 304. Canada Drug Discovery Software, by Type USD Million (2023-2028)
  • Table 305. Canada Drug Discovery Software, by Application USD Million (2023-2028)
  • Table 306. Canada Drug Discovery Software, by Deployment Mode USD Million (2023-2028)
  • Table 307. Canada Drug Discovery Software, by Organization Size USD Million (2023-2028)
  • Table 308. Canada Drug Discovery Software, by End Users USD Million (2023-2028)
  • Table 309. Mexico Drug Discovery Software, by Type USD Million (2023-2028)
  • Table 310. Mexico Drug Discovery Software, by Application USD Million (2023-2028)
  • Table 311. Mexico Drug Discovery Software, by Deployment Mode USD Million (2023-2028)
  • Table 312. Mexico Drug Discovery Software, by Organization Size USD Million (2023-2028)
  • Table 313. Mexico Drug Discovery Software, by End Users USD Million (2023-2028)
  • Table 314. Drug Discovery Software: by Type(USD/Units)
  • Table 315. Research Programs/Design for This Report
  • Table 316. Key Data Information from Secondary Sources
  • Table 317. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Drug Discovery Software: by Type USD Million (2017-2022)
  • Figure 5. Global Drug Discovery Software: by Application USD Million (2017-2022)
  • Figure 6. Global Drug Discovery Software: by Deployment Mode USD Million (2017-2022)
  • Figure 7. Global Drug Discovery Software: by Organization Size USD Million (2017-2022)
  • Figure 8. Global Drug Discovery Software: by End Users USD Million (2017-2022)
  • Figure 9. South America Drug Discovery Software Share (%), by Country
  • Figure 10. Asia Pacific Drug Discovery Software Share (%), by Country
  • Figure 11. Europe Drug Discovery Software Share (%), by Country
  • Figure 12. MEA Drug Discovery Software Share (%), by Country
  • Figure 13. North America Drug Discovery Software Share (%), by Country
  • Figure 14. Global Drug Discovery Software: by Type USD/Units (2017-2022)
  • Figure 15. Global Drug Discovery Software share by Players 2022 (%)
  • Figure 16. Global Drug Discovery Software share by Players (Top 3) 2022(%)
  • Figure 17. Global Drug Discovery Software share by Players (Top 5) 2022(%)
  • Figure 18. BCG Matrix for key Companies
  • Figure 19. Epocrates (United States) Revenue, Net Income and Gross profit
  • Figure 20. Epocrates (United States) Revenue: by Geography 2022
  • Figure 21. Thermo Scientific Nautilus LIMS (United States) Revenue, Net Income and Gross profit
  • Figure 22. Thermo Scientific Nautilus LIMS (United States) Revenue: by Geography 2022
  • Figure 23. ChemDraw (PerkinElmer) (United States) Revenue, Net Income and Gross profit
  • Figure 24. ChemDraw (PerkinElmer) (United States) Revenue: by Geography 2022
  • Figure 25. MicroTracker (Norway) Revenue, Net Income and Gross profit
  • Figure 26. MicroTracker (Norway) Revenue: by Geography 2022
  • Figure 27. DrugPatentWatch (United States) Revenue, Net Income and Gross profit
  • Figure 28. DrugPatentWatch (United States) Revenue: by Geography 2022
  • Figure 29. AutoDock (Scripps Research) (United States) Revenue, Net Income and Gross profit
  • Figure 30. AutoDock (Scripps Research) (United States) Revenue: by Geography 2022
  • Figure 31. Collaborative Drug Discovery Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Collaborative Drug Discovery Inc. (United States) Revenue: by Geography 2022
  • Figure 33. DrugDev Spark (United States) Revenue, Net Income and Gross profit
  • Figure 34. DrugDev Spark (United States) Revenue: by Geography 2022
  • Figure 35. DSG Drug Safety (United States) Revenue, Net Income and Gross profit
  • Figure 36. DSG Drug Safety (United States) Revenue: by Geography 2022
  • Figure 37. PEPID PDC (United States) Revenue, Net Income and Gross profit
  • Figure 38. PEPID PDC (United States) Revenue: by Geography 2022
  • Figure 39. Global Drug Discovery Software: by Type USD Million (2023-2028)
  • Figure 40. Global Drug Discovery Software: by Application USD Million (2023-2028)
  • Figure 41. Global Drug Discovery Software: by Deployment Mode USD Million (2023-2028)
  • Figure 42. Global Drug Discovery Software: by Organization Size USD Million (2023-2028)
  • Figure 43. Global Drug Discovery Software: by End Users USD Million (2023-2028)
  • Figure 44. South America Drug Discovery Software Share (%), by Country
  • Figure 45. Asia Pacific Drug Discovery Software Share (%), by Country
  • Figure 46. Europe Drug Discovery Software Share (%), by Country
  • Figure 47. MEA Drug Discovery Software Share (%), by Country
  • Figure 48. North America Drug Discovery Software Share (%), by Country
  • Figure 49. Global Drug Discovery Software: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Epocrates (United States)
  • Thermo Scientific Nautilus LIMS (United States)
  • ChemDraw (PerkinElmer) (United States)
  • MicroTracker (Norway)
  • DrugPatentWatch (United States)
  • AutoDock (Scripps Research) (United States)
  • Collaborative Drug Discovery Inc. (United States)
  • DrugDev Spark (United States)
  • DSG Drug Safety (United States)
  • PEPID PDC (United States)
Additional players considered in the study are as follows:
Schrodinger Discovery Informatics Suite (United States) , Advera Health (United States) , American Gene Technologies (United States) , Aurora Drug Discovery Software (United States) , BIOVIA Discovery Studio (United States)
Select User Access Type

Key Highlights of Report


Dec 2023 225 Pages 50 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Drug Discovery Software Market Quantitative research analysis
Global Drug Discovery Software Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Drug Discovery Software market are Epocrates (United States), Thermo Scientific Nautilus LIMS (United States), ChemDraw (PerkinElmer) (United States), MicroTracker (Norway), DrugPatentWatch (United States), AutoDock (Scripps Research) (United States), Collaborative Drug Discovery Inc. (United States), DrugDev Spark (United States), DSG Drug Safety (United States) and PEPID PDC (United States), to name a few.
"Rapidly Adoption of the Artificial Intelligence and Deep Learning Technology" is seen as one of major influencing trends for Drug Discovery Software Market during projected period 2022-2028.
is dominating the Drug Discovery Software Market.
The Drug Discovery Software market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete of companies available in our research coverage.

Know More About Global Drug Discovery Software Market Report?

Have a Query? Click Here

Other Related Reports

AI in Construction Comprehensive Study by Application (Project management, Field management, Risk management, Schedule management, Supply chain management, Others), Organization Size (Residential, In...
$ 3750
Online Money Transfer Software Comprehensive Study by Platform (Windows, Linux, Android, IoS), Pricing (Monthly, Annually, One time license), Deployment (Cloud, On premise), Features (Bank money tran...
$ 3450
Web Font Marketplace Software Comprehensive Study by Application (Large Size Enterprises, Small-medium Size Enterprises), Pricing Option (Monthly Subscription, Annual Subscription, Free), Platform (S...
$ 3650
Auto Body Software Comprehensive Study by Application (Large Scale Auto Repair Shops, Small and Medium Auto Repair Shops), Pricing Option (Monthly Subscription, Annual Subscription, One-Time License)...
$ 3750
Software Defined Wide Area Comprehensive Study by Type (Virtual Appliance, Physical Appliance, Hybrid), Deployment Mode (On-premises, Cloud), Service Type (Consulting, Implementation, Training, Suppo...
$ 3650
English Learning Application Comprehensive Study by Application (Academic Institution, Business, Vocational Tests), Pricing Option (Free, Subscription {Annual, Monthy}), Device (Smartphones, Tablet, ...
$ 3450